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CASE REPORT

Botulism in Children: A Diagnostic Dilemma in
Developing Countries

Muhammad Rehan Khan, Prem Kumar Maheshwari, Shahnaz Hamid Ibrahim and Anwarul Haque

ABSTRACT

Botulism is a well-known disease of the neuromuscular junction. It is a rare but curable cause of paralysis in paediatric
population. In addition to classical clinical signs and symptoms, the diagnosis of botulism requires laboratory confirmation
of intoxication by various biological tests. These include demonstration of botulinum toxin in serum or isolation of the
Clostridium botulinum from stool/gastric aspirates. However, it is not always possible to confirm intoxication due to
unavailability of technical facilities, especially in resource limited countries like Pakistan. Under these circumstances,
electrophysiological studies serve as an excellent diagnostic tool. These studies can provide quick diagnosis of botulism
so that early administration of botulism immunoglobulin, if available, can reduce morbidity, mortality and length of stay in
hospital. We report a case of botulism from Pakistan diagnosed on the basis of electrophysiological studies.
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INTRODUCTION

Botulism is a rare systemic paralytic disorder, especially
beyond the infantile age group. It is caused by
Clostridium botulinum, which produces a neurotoxin
responsible for the clinical manifestations.1 In the United
States; about 110 cases of botulism are reported each
year. Most of these cases are seen in infants. In
children, it is rarely reported suggesting that it is an
uncommon condition beyond infantile age group.2 In
England and Wales, only 6 cases of infant botulism were
reported by health protection agency between 1975 and
2006.3 However, some recent studies have shown a
rising trend in the incidence of infant botulism in UK.4
There is very limited reported data about botulism in
developing countries.

Establishing the diagnosis of botulism can prove to be
very challenging. Sometimes, even classical cases may
be misdiagnosed as neuromuscular disorders while
on the other hand, some milder cases may go
undiagnosed, if not suspected and worked up actively.5
Several clinical mimics also need to be differentiated to
rule out other etiologies as this can lead to false
diagnosis and treatment.6 Botulinum immunoglobulin
(BIG-IV) is the treatment of choice and can significantly
reduce the morbidity, hospital stay and expenses of the
treatment, especially if given early in the course of
disease.7

CASE REPORT

An 8 years old child was admitted with acute history of
dysphagia, ptosis of left eye and generalized weakness.
No fever, seizures or altered mental status were
reported. On physical examination, the child was
afebrile, with normal vital signs. Neurological examination revealed decreased pupillary response to light;
third and seventh cranial nerves involvement, weak gag
reflex and absent deep tendon reflexes. An initial
differential diagnosis of Guillain-Barre syndrome,
brainstem encephalitis, poliomyelitis and botulism was
made. Lumbar puncture showed a normal CSF; all
other laboratory findings were normal as were the
CT scanning and MRI findings of the brain. The
child developed respiratory arrest on second day of
admission hence, intubated and shifted to paediatric
intensive care unit. Stool cultures were sent for polio
while no biologic tests were available for botulism. Initial
electrophysiological studies were normal so treated on
the lines of Guillain-Barré syndrome on empiric basis.
As the child did not respond to standard treatment
and there was high clinical suspicion of botulism,
electrophysiological studies were repeated. This time,
the studies were highly consistent with botulism showing
incremental response on repetitive nerve stimulation
(Figures 1 and 2).
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Figure 1: Repetitive nerve stimulation
of ulnar nerve demonstrating 93%
increment.
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Figure 2: Repetitive nerve stimulation
of median nerve demonstrating
53% increment.
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No antitoxin was administered due to non-availability in
Pakistan. Mechanical ventilation was continued. Later
on, tracheostomy was done as the child needed
prolonged respiratory support. The child remained on
ventilator for about 6 weeks. Nasogastric feeding started
along with other supportive measures. Child showed
gradual recovery after 4 – 5 weeks, starting with
improvement in ptosis. Full recovery of cranial nerves
was achieved in 8 weeks. At discharge, the child was
able to walk with support. On follow-up, complete clinical
recovery was noted and tracheostomy was decanulated.

DISCUSSION

Botulinum toxins block the release of acetylcholine from
presynaptic cholinergic nerve terminals at neuromuscular junctions, thus leading to all its clinical
manifestation. The signs and symptoms closely
resemble to its differential diagnosis like GuillainBarré syndrome, especially its Miller-Fisher variant,
myasthenia gravis and other neurological diseases. For
accurate diagnosis of botulism, demonstration of its
toxin, either in stool or blood, is considered to be gold
standard but these biological tests are not readily
available in most developing countries including
Pakistan. However, electrophysiological studies of
botulism demonstrate characteristic defects of neuromuscular transmission,8,9 so that a suggestive clinical
picture combined with these electrophysiological
findings can be considered as the best method for the
diagnosis of botulism in resource limited countries. In
particular, electrophysiological testing is of great
advantage for the early diagnosis of suspected cases
even before the results of bacteriological tests, if
available, so that antitoxin can be given earlier to reduce
the morbidity and length of stay in the hospital. In this
patient, blood and cerebrospinal fluid test results were
normal along with CT scan and MRI of brain. Even initial
EMG/nerve conduction velocity studies were normal but
the patient demonstrated the classic features of
botulism: progressive muscle weakness, cranial nerve
palsies followed by sudden respiratory arrest. Since
such a sequence of events may lead to serious
consequences, early diagnosis and intervention is
necessary.
Repetitive nerve stimulation (RNS) enables us to assess
the status of neuromuscular junctions directly. Although
increments in response to repetitive nerve stimulation
are characteristic of both lambert-eaton myasthenic
syndrome (LEMS) and botulism but in case of LEMS
marked incremental response (> 200%) is seen while in
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botulism, only modest (50 – 100%) incremental response
is seen.10 In case of myasthenia gravis, a normal or
decremental response is seen in response to repetitive
nerve stimulation.10 In this patient, repetitive nerve
stimulation demonstrated 93% increment in ulnar nerve
and 53% increment in median nerve (Figures 1 and 2)
which are characteristic and diagnostic of botulism.
Thus, an early and accurate diagnosis of botulism can
be made with the help of electrophysiological studies.
There is limited data available about the cases of
childhood botulism suggesting that it may be underrecognized, underreported or both. When bulbar palsies,
hypotonia and weakness are present, clinicians
should have a high index of suspicion for botulism.
Electrophysiological studies are important diagnostic
tool especially when stool culture and other biologic
laboratory tests facilities are not available.
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